ProRetina Therapeutics is a company that provides Retinal Disorder, Lampalizumab, Angiogenesis inhibitor and more. ProRetina Therapeutics is headquartered in Spain Madrid. ProRetina Therapeutics was founded in 2007. and was founded by Stuart Medina Miltimore, Stuart Medina Miltimore.